BMS II Definitions/Abbreviations

5.0(1)
studied byStudied by 40 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/116

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

117 Terms

1
New cards

what the body does to the drug

pharmacokinetics

2
New cards

what the drug does to the body

pharmacodynamics

3
New cards

What is this the definition of?

Chemical substances found within an organism that are not naturally produced or recognized within the organism.

xenobiotics

4
New cards

Why does the human body restrict access to xenobiotics?

body doesn’t know if drugs are good or bad for us

5
New cards

Cmax is the max ________ in the blood

concentration

6
New cards

Tmax is the time it takes to reach _______.

Cmax

7
New cards

During which of the ADME processes can drug interactions occur?

ALL

8
New cards

How do

  • solubility

  • sterics

  • electronics

pertain to biological barriers?

solubility- “goldilocks” not to hydrophobic/phillic

sterics- size can’t be too big

electronics- nonpolar molecules cross membranes easier

9
New cards

What does the following equation represent?

F= amount of drug that reaches circulation/ amount of drug that is administered

bioavailability

10
New cards

If a drug passes all of Lipinski’s rules, would it likely be inactive or active drug?

active

11
New cards

True or False: Lipinski’s rule states that a drug-like molecule cannot have more than 10 hydrogen bond acceptors

True

12
New cards

What are the four parameters for Lipinski’s rule?

  1. how many H-bond donors?

  2. how many H-bond acceptors?

  3. What molecular weight?

  4. What Log P?

≤5 H-bond donors

≤ 10 H-bond acceptors

< 500 molecular weight

≤ 5 Log P

13
New cards

a semipermeable membrane in the brain that is characterized by tight junctions and astrocytes.

(a lot less permeable compared to a normal capillary)

Blood-Brain Barrier (BBB)

14
New cards

_____________ are pharmacologically inactive compounds that are converted to their active forms by metabolism.

Prodrug

15
New cards

What is the correlation between the amount of substance administered and amount of substance in systemic circulation?

Volume of distribution

16
New cards

creatinine definition

A waste product produced by muscles from the breakdown of creatine phosphate. It is filtered by the kidneys and excreted in urine. Elevated levels indicate kidney dysfunction.

17
New cards

p-glycoprotein definition

A protein found in cell membranes that acts as a pump to remove foreign substances, like drugs, from cells. It plays a role in drug resistance and limiting the absorption of certain medications in the body.

18
New cards

Isozyme definition

enzymes that differ in amino acid sequence but catalyze the same chemical reaction

19
New cards

ligand definition

molecule that binds to the receptor

20
New cards

Therapeutic Window definition

reflects a concentration range that provides efficacy without unacceptable toxicity

21
New cards

therapeutic index defintion

a measure of a drug's safety and effectiveness. It is the ratio between the dose that produces therapeutic effects and the dose that causes toxic effects.

22
New cards

A (higher/lower) therapeutic index indicates a safer drug.

Higher

23
New cards

Area under the curve Abbreviation

AUC

24
New cards

Clearance (abbr and definition)

  • Cl

  • a measure of the body’s efficiency in eliminating drug from the systemic circulation

25
New cards

bioavailability (abbr and definition)

  • F

  • the fraction of drug absorbed into the systemic circulation

26
New cards

What are the 3 ways drugs can be eliminated using the renal system?

  1. filtration

  2. secretion

  3. reabsorption

27
New cards

CYPs (abbr and defintion)

cytochrome P450 enzymes

  • responsible for 75% of drug metabolism

  • first pass metabolism

28
New cards

Vd abbreviation

volume of distribution

29
New cards

GCPR

G protein-coupled receptor

30
New cards

What is the kidney blood flow per minute?

1.2-1.5 L

31
New cards

NF-kB

nuclear factor-κB

  • Transcription factor involved in immune response and inflammation.

32
New cards

MAPK abbr

mitogen-activated protein kinase

33
New cards

Kd

acid dissociation constant

34
New cards

ED50

half-maximally effective dose

35
New cards

TD50

half-maximally toxic dose

36
New cards

LD 50

half-maximal lethal dose

37
New cards

The larger the volume of distribution indicates what about the drug molecule?

More hydrophobic

38
New cards

Calculate the volume of distribution for the following drug:

  • Dose= 400 mg

  • Cmax= 0.06 mg/L

Vd=

6667

39
New cards

(increased/decreased) clearance indicates that more was removed from the body.

increased

40
New cards

What is based upon the max response to the ligand?

efficacy

41
New cards

____________ has positive efficacy

____________ has zero efficacy

____________ has negative efficacy

agonist, antagonist, inverse

42
New cards

The greater the potency, the smaller the dose at which ______ occurs.

a. EC50

b. TC50

c. LC50

a (EC50)

43
New cards
<p>According to the graph, which drug is the most potent? which drug is the more effective?</p>

According to the graph, which drug is the most potent? which drug is the more effective?

Most potent- 1

More effective- 2&3 are equal

44
New cards

What kind of agonist is able to produce the maximum response?

full agonist

45
New cards

What kind of agonist is able to produce a sub-maximal response?

partial agonist

46
New cards

What kind of agonist binds to the same site on the receptor as the endogenous ligand?

orthosteric

47
New cards

What kind of agonist binds to a different site on the receptor as the endogenous ligand?

allosteric

48
New cards

Drugs that occupy receptors and activate them are ___________.

While drugs that occupy receptors but do not activate them are __________.

agonists, antagonists

49
New cards

What is the measure of strength of drug-receptor binding and how do we measure that strength?

affinity, Kd

50
New cards

If a drug has an affinity of 80%, if we wanted to find the ED50, what percent would we be looking at?

40%

51
New cards

More affinity = ______ potent

more

52
New cards

What term is used to describe your baseline? This is what the body attempts to restore after the effects of drugs.

Status Quo

53
New cards

___________ is the reduced effects/ reaction to drug following repeated use.

a. dependence

b. tolerance

c. tachyphylaxis

d. attenuation

tolerance

54
New cards

How can tolerance be overcome?

a. increasing # of receptors

b. increasing dose

c. decreasing dose

d. stopping drug use immediately

b

55
New cards

____________ can be physiological and/or psychological. It is when your baseline functionality needs a drug.

Alternative defintion:

Physiological effect: need drug in order to achieve baseline state Psychological effect: fear of not having the drug due to withdrawal/subtherapeutic situation

Dependence

56
New cards

Can you be addicted to redbull?

Can you be dependent on redbull?

addicted- no

dependent- yes

57
New cards

What is the main difference between addiction and dependence?

the psychocomponent. in addiction you seek drug in order to achieve pleasure associated with taking drug

58
New cards

What term describes the following?

Short-term tolerance to a drug or treatment. Repeated exposure leads to diminished response.

a. fade

b. resistance

c. tachyphylaxis

d. attenuation

c

59
New cards

True or False: Tachyphylaxis is non-reversible

FALSE

60
New cards

______________: drug binds, decreased response

______________: # of receptors decreases

desensitization, downregulation

61
New cards

True of False: Feedback Regulation may occur at cellular or system level, and be delayed or immediate.

TRUE

62
New cards

Attenuation is the decrease of response at the __________ level.

receptor

63
New cards

An increased response to a drug with prolonged use is:

a. sensitization

b. desensitization

c. reverse tolerance

d. tolerance

SATA

a,c

64
New cards

Abrupt removal of what causes supersensitivity?

antagonist

65
New cards

How does supersensitivity differ from sensitization?

sensitization- increase response to a drug with prolonged use

supersensitivity- abrupt antagonist removal results in increased receptor activity.

66
New cards

Monica is a 62-year-old woman with diabetes. She takes Lantus, and over the next couple months her cells express fewer insulin receptors. This is an example of:

a. upregulation

b. tachyphylaxis

c. dependence

d. downregulation

d

67
New cards

What is a type A (ADR)?

a. based on the mechanism of action

b. idiopathic, causes something else

c. based on the physiochemical properties

d. idiopathic, causes it’s intended action

a

68
New cards

What is a type B (ADR)?

a. based on the mechanism of action

b. idiopathic, causes something else

c. based on the physiochemical properties

d. idiopathic, causes it’s intended action

b

69
New cards

What do the following abbreviations stand for:

  1. FDA

  2. ISMP

  3. WHO

And which ones, are ADRs reported to?

  1. food and drug administration

  2. Institute for Safe Medication Practices

  3. World Health Organization

ADRS reported to all 3 organizations

70
New cards

Why do ADRs happen? We are changing ____________.

homeostasis

71
New cards
  1. ___________ __________ range of efficacy without toxicity/lethality

  2. ___________ __________ ratio of toxicity/lethality to efficacy

  1. therapeutic window

  2. therapeutic index

72
New cards

What is the Therapeutic Index when 400 mg of Drug A causes LD50 and 50mg of Drug A causes ED50?

8

73
New cards

What type of receptor is a protein that binds endogenous ligands?

physiological receptor

74
New cards

A receptor is acting without a ligand binding to it and producing activity.

What does this describe?

constitutive activity

75
New cards

What/ Who makes endogenous ligands?

your body

76
New cards

Drugs that mimic the effects of endogenous ligands are ____________.

agonists

77
New cards

__________-receptor binding will create/enhance biological effect

agonist

78
New cards

Does the concentration of agonist have anything to do with efficacy?

Yes

79
New cards

Where do primary agonists bind?

Where do allosteric agonists bind?

  • same site as endogenous ligand (orthosteric site)

  • different site as endogenous ligand

80
New cards

A ______________ enhances the effect of a drug by binding to another substance.

potentiator

81
New cards

What do antagonists do to the actions of agonists?

SATA

a. reduce

b. induce

c. block

d. release

a, c

82
New cards

When an agonist and antagonist compete for the same binding site.

a. competitive

b. allosteric

c. chemical

d. physiological

a

83
New cards

Binds to a different site on the receptor

a. competitive

b. allosteric

c. chemical

d. physiological

b

84
New cards

Binds to the agonist and prevents agonist from binding

a. competitive

b. allosteric

c. chemical

d. physiological

c

85
New cards

A drug that counters the effects of another by binding to a different receptor and causing opposing effects

a. competitive

b. allosteric

c. chemical

d. physiological

d

86
New cards

A graph of increasing response to increasing drug concentration or dose is a

__________-_______ response curve

graded-dose response curve

87
New cards

A graph of the fraction of a population that shows a specified response at progressively increasing doses is a __________-_______ response curve.

quantal dose

88
New cards

A competitive antagonist binds to the ___________ site.

orthosteric

89
New cards

With an uncompetitive antagonist, the antagonist binds to the ____________ site. Additionally, inhibition requires binding of the ___________.

allosteric, agonist

90
New cards

With inverse agonists, what is the key consideration?

constitutive activity

91
New cards

What binds to the allosteric site and enhances agonist activity?

allosteric potentiator

92
New cards

What can antagonists effect?

a. potency

b. efficacy

c. both

c

93
New cards

Why might chemical antagonists decrease affinity of agonists?

Chemical antagonists bind to agonist, so less binding/affinity to form the drug-receptor complex

94
New cards

competitive antagonists _______________ the potency of agonists

a. increase

b. decrease

b

95
New cards

Allosteric and Pseudoirreversible antagonists do what to potency?

decrease

96
New cards

Allosteric and irreversible antagonists do what to efficacy?

decrease

97
New cards

Allosteric potentiators impact the dose-response curve how?

increase potency

98
New cards

occupancy in terms of pharmacology is defined as

when a drug binds to the receptor, the receptor is occupied

99
New cards

What term is used to describe the % of receptors that are occupied by a drug

fractional occupancy

100
New cards

If a receptor has no constitutive activity, what will be the effect of an inverse agonist on that receptor?

decrease potency